Journal of Molecular Nanotechnology and Nanomedicine

Editor in Chief

Andre Chwalibog completed his DSc in 1985 at the Royal Veterinary and Agricultural University, Copenhagen, Denmark. He is professor at the University of Copenhagen, Faculty of Health and Medical Sciences and also is currently working as visiting professor at Warsaw University of Life Sciences. A total 389 publications, out of which 194 peer reviewed,…

Name : Andre Chwalibog
University : University of Copenhagen

Indexing and Listing

          

Recent Articles

  • article image

    Nanoconstructs for Cancer Therapy and Imaging

    The complexity of the cancer disease and prevalence of diverse cell populations warrants a highly specific treatment for cancer. The application of nanotechnology towards cancer therapy is one of the advanced approaches to overcome the limitation of conventional chemotherapy. Nanotechnology based carriers are engineered using biomaterials that provide…

    View more
  • article image

    Study DNA Damage after Photodynamic Therapy Using Silver Nanoparticles with A549 Cell Line

    Lung Cancer is one of the major health problems worldwide. Nanomedicine is considered as one of the promising research applications nowadays. This is due to the unique physical and chemical properties of the nanoscale elements. Silver nanoparticles (Ag NPs) in specific has been extensively studied recently in many biomedical applications especially…

    View more

PubMed Indexed Articles

  • article image

    Homeodomain Transcription Factor Msx-2 Regulates Uterine Progenitor Cell Response to Diethylstilbestrol

    The fate of mouse uterine epithelial progenitor cells is determined between postnatal days 5 to 7. Around this critical time window, exposure to an endocrine disruptor, diethylstilbestrol (DES), can profoundly alter uterine cytodifferentiation. We have shown previously that a homeo domain transcription factor MSX-2 plays an important role in DES-responsiveness…

    View more
  • article image

    Brain Uptake of Neurotherapeutics after Intranasal Delivery in Mice

    There is a growing global prevalence of neurodegenerative diseases such as Alzheimer’s disease and dementia. Current treatment for neurodegenerative diseases is limited due to the blood brain barrier’s ability to restrict the entry of therapeutics to the brain. In that context, direct delivery of drugs from nose to brain has gained emerging interest…

    View more
  • article image

    Current Studies of Immunotherapy on Glioblastoma

    Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alternative to conventional treatment for glioblastomas is immunotherapy. Although proposed over a century ago, the field of cancer immunotherapy…

    View more

Testimonial